Ping An Healthcare and Technology Company (1833) AI Stock Analysis

• Market Cap: $21.79B
• Dividend Yield: N/A
• Average Volume (3M): 13.68M
• Price to Earnings (P/E): 124.9
• Beta (1Y): 1.40
• Revenue Growth: 1.01%
• EPS Growth: N/A
• Country: HK
• Employees: 1,563
• Sector: Healthcare
• Sector Strength: 41
• Industry: Medical - Healthcare Information Services
• EPS (TTM): N/A
• Shares Outstanding: 2,161,443,600
• 10 Day Avg. Volume: 13,038,032
• 30 Day Avg. Volume: 13,675,795
• PEG Ratio: -5.03
• Price to Book (P/B): 2.77
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -48.94
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: $8.01
• Price Target Upside: -20.57% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 56 Neutral
• Price Target: HK$10.00 ▼(-0.79%Downside)

The stock score is driven primarily by technical analysis factors, indicating strong momentum despite overbought signals. Financial performance presents a mixed picture with robust cash reserves but inconsistent revenue and free cash flow. Valuation concerns with a high P/E ratio and lack of dividend yield contribute to a lower score.

Ping An Healthcare and Technology Company Business Overview & Revenue Model

Company Description

Ping An Healthcare and Technology Company, also known as Ping An Good Doctor, is a leading provider of online healthcare services in China. The company is a subsidiary of the Ping An Insurance Group, and it operates in the healthtech sector, offering online medical consultations, health management, and wellness services through its mobile platform. Its core products include online hospital services, consumer healthcare services, and health mall offerings, which provide users with a comprehensive suite of healthcare solutions accessible from their smartphones.

How the Company Makes Money

Ping An Healthcare and Technology Company generates revenue primarily through its online healthcare platform. Key revenue streams include fees from online medical consultations, where users pay for virtual visits with healthcare professionals. The company also earns money through its health mall, which sells a wide range of health-related products, including pharmaceuticals, medical devices, and wellness goods. Furthermore, Ping An Good Doctor partners with insurance companies to offer health management services, thus earning commissions and service fees. These partnerships, along with a large user base and the backing of the Ping An Insurance Group, significantly contribute to its earnings.

Ping An Healthcare and Technology Company Financial Statement Overview

Summary

The company displays mixed financial health. Healthy cash reserves and recent profitability improvements are positive indicators. However, volatile revenue growth, negative EBIT and EBITDA margins, and inconsistent free cash flow pose risks. The balance sheet is robust with low leverage.

Income Statement

The company shows a concerning trend in profitability with negative EBIT and EBITDA margins over the years. However, there is a recent improvement in net income, indicating potential recovery. The gross profit margin remains healthy, but revenue growth has been volatile, signaling uncertainty in financial performance.

Balance Sheet

The company maintains strong cash reserves as indicated by the substantial cash and short-term investments. The debt-to-equity ratio is low, suggesting conservative use of leverage. However, the return on equity is weak due to inconsistent net income, which could be a potential risk if profitability does not stabilize.

Cash Flow

There is a positive shift in operating cash flow, moving from negative to positive, suggesting improvement in cash generation. However, free cash flow remains inconsistent, which could impact future investments. The free cash flow to net income ratio shows improvement, but overall cash flow stability needs attention.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	4.81B	4.67B	6.16B	7.33B	6.87B
Gross Profit	1.52B	1.51B	1.68B	1.71B	1.86B
EBITDA	193.43M	-164.23M	-1.02B	-1.76B	-605.20M
Net Income	81.43M	-322.59M	-607.57M	-1.54B	-948.48M
Balance Sheet
Total Assets	16.78B	16.52B	17.14B	17.88B	18.56B
Cash, Cash Equivalents and Short-Term Investments	11.52B	11.42B	10.14B	10.14B	13.53B
Total Debt	45.00M	93.61M	176.49M	201.29M	113.97M
Total Liabilities	13.20B	3.25B	3.68B	3.79B	2.71B
Stockholders Equity	3.59B	13.28B	13.46B	14.08B	15.83B
Cash Flow
Free Cash Flow	65.08M	-325.82M	-845.05M	-1.49B	-1.18B
Operating Cash Flow	99.33M	-282.86M	-810.62M	-1.40B	-1.10B
Investing Cash Flow	114.65M	-1.49B	1.71B	-3.10B	-2.50B
Financing Cash Flow	-38.44M	-67.36M	-317.88M	-319.91M	6.92B

Ping An Healthcare and Technology Company Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 10.08
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Negative
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1833, the sentiment is Positive. The current price of 10.08 is above the 20-day moving average (MA) of 9.39, above the 50-day MA of 8.17, and above the 200-day MA of 6.82, indicating a bullish trend. The MACD of 0.45 indicates Positive momentum. The RSI at 71.74 is Negative, neither overbought nor oversold. The STOCH value of 49.97 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1833.

Ping An Healthcare and Technology Company Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2276	75 Outperform	HK$19.32B	36.13	28.81%	0.02%	14.99%	31.70%
Sector *	60 Neutral	HK$16.95B	5.65	-7.44%	2.87%	11.55%	-28.15%
1833	56 Neutral	$21.79B	124.91	0.96%	―	1.01%	―
1952	54 Neutral	HK$25.41B	―	-23.03%	―	461.36%	-16.43%
2159	48 Neutral	HK$379.20M	―	-48.20%	―	-4.57%	52.37%
2158	45 Neutral	HK$6.06B	―	-2.97%	―	11.00%	56.87%
2251	44 Neutral	HK$1.35B	―	-18.19%	―	-24.50%	-93.44%

Ping An Healthcare and Technology Company Corporate Events

Ping An Healthcare Announces Board Composition and Roles

Ping An Healthcare and Technology Company Limited has announced the composition of its board of directors and their roles within the company. The announcement outlines the executive, non-executive, and independent non-executive directors, along with their participation in various board committees, which include the Audit and Risk Management Committee, Nomination and Remuneration Committee, and Sustainable Development Committee. This update is significant as it reflects the company’s governance structure and commitment to sustainable development, potentially impacting its strategic direction and stakeholder engagement.

The most recent analyst rating on (HK:1833) stock is a Hold with a HK$12.00 price target. To see the full list of analyst forecasts on Ping An Healthcare and Technology Company stock, see the HK:1833 Stock Forecast page.

Ping An Healthcare Announces Leadership Changes

Ping An Healthcare and Technology Company Limited announced the resignation of Mr. Jun Wu as an executive director and president, effective July 10, 2025, due to personal work arrangements. The company assures stakeholders that operations will remain unaffected and governance will continue to be efficient. Concurrently, Ms. Luoqi Zang has been appointed as an executive director. Ms. Zang, who joined the company in 2022, brings extensive experience in financial and operational management, having previously worked with prominent firms like PricewaterhouseCoopers and Didi Chuxing. Her appointment is expected to bolster the company’s strategic direction and operational oversight.

The most recent analyst rating on (HK:1833) stock is a Buy with a HK$12.20 price target. To see the full list of analyst forecasts on Ping An Healthcare and Technology Company stock, see the HK:1833 Stock Forecast page.

Ping An Healthcare Approves Key Resolutions at AGM

Ping An Healthcare and Technology Company Limited held its Annual General Meeting on June 26, 2025, where all proposed resolutions were approved by shareholders. Key resolutions included the adoption of the company’s audited financial statements, re-election of directors, and the appointment of Ernst & Young as the auditor. The meeting also granted the board mandates to issue and buy back shares, reflecting strong shareholder support and potentially impacting the company’s market operations and strategic flexibility.

The most recent analyst rating on (HK:1833) stock is a Hold with a HK$12.00 price target. To see the full list of analyst forecasts on Ping An Healthcare and Technology Company stock, see the HK:1833 Stock Forecast page.

Ping An Healthcare Announces 2025 AGM Agenda

Ping An Healthcare and Technology Company Limited has announced its upcoming annual general meeting scheduled for June 26, 2025, in Shanghai. Key agenda items include the adoption of the 2024 financial statements, re-election of directors, and appointment of Ernst & Young as the company’s auditor. The meeting will also consider resolutions to authorize the board to manage share allotments and related financial instruments, indicating a strategic focus on financial governance and operational continuity.

The most recent analyst rating on (HK:1833) stock is a Hold with a HK$12.00 price target. To see the full list of analyst forecasts on Ping An Healthcare and Technology Company stock, see the HK:1833 Stock Forecast page.

Ping An Healthcare Announces Auditor Change to Ernst & Young

Ping An Healthcare and Technology Company Limited has announced a proposed change of auditor, with PricewaterhouseCoopers retiring after more than seven years of service. The company plans to appoint Ernst & Young as the new auditor, subject to shareholder approval at the upcoming annual general meeting. This change aims to maintain good corporate governance and ensure the independence and objectivity of the auditing process, aligning with the Corporate Governance Code and benefiting the company and its shareholders.

The most recent analyst rating on (HK:1833) stock is a Hold with a HK$12.00 price target. To see the full list of analyst forecasts on Ping An Healthcare and Technology Company stock, see the HK:1833 Stock Forecast page.